These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29881406)

  • 1. Co -delivery of Sulforaphane and Curcumin with PEGylated Iron Oxide-Gold Core Shell Nanoparticles for Delivery to Breast Cancer Cell Line.
    Danafar H; Sharafi A; Kheiri S; Kheiri Manjili H
    Iran J Pharm Res; 2018; 17(2):480-494. PubMed ID: 29881406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Characterization of PEGylated Iron Oxide-Gold Nanoparticles for Delivery of Sulforaphane and Curcumin.
    Danafar H; Sharafi A; Askarlou S; Manjili HK
    Drug Res (Stuttg); 2017 Dec; 67(12):698-704. PubMed ID: 28738425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAMAM-modified citric acid-coated magnetic nanoparticles as pH sensitive biocompatible carrier against human breast cancer cells.
    Nosrati H; Adibtabar M; Sharafi A; Danafar H; Hamidreza Kheiri M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1377-1384. PubMed ID: 29560737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
    Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
    Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Effect of Self-Assembled Curcumin and Piperine Co-Loaded Human Serum Albumin Nanoparticles on Suppressing Cancer Cells.
    Abolhassani H; Safavi MS; Handali S; Nosrati M; Shojaosadati SA
    Drug Dev Ind Pharm; 2020 Oct; 46(10):1647-1655. PubMed ID: 32892656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of magnetic gold nanoparticles to be used as doxorubicin nanocarriers.
    Elbialy NS; Fathy MM; Khalil WM
    Phys Med; 2014 Nov; 30(7):843-8. PubMed ID: 24950615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monodisperse Rattle-Structured Gold Nanorod-Mesoporous Silica Nanoparticles Core-Shell as Sulforaphane Carrier and its Sustained-Release Property.
    Manjili HK; Ma'mani L; Naderi-Manesh H
    Drug Res (Stuttg); 2018 Sep; 68(9):504-513. PubMed ID: 29660748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
    Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excogitation and Assessment of Curcumin-Vitamin E Self-assembly PEGylated Nanoparticles by the Route of Oral Administration.
    Huang Z; Chen X; Li Y; Zhai J; Ma Y
    J Pharm Sci; 2021 Jan; 110(1):146-154. PubMed ID: 32979362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalizing the surface of hydroxyapatite drug carrier with carboxylic acid groups to modulate the loading and release of curcumin nanoparticles.
    Lee WH; Loo CY; Rohanizadeh R
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():929-939. PubMed ID: 30889767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells.
    Hasanpoor Z; Mostafaie A; Nikokar I; Hassan ZM
    Int J Biol Macromol; 2020 Sep; 159():137-153. PubMed ID: 32335119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line.
    Doggui S; Sahni JK; Arseneault M; Dao L; Ramassamy C
    J Alzheimers Dis; 2012; 30(2):377-92. PubMed ID: 22426019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
    Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
    J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D, L-Sulforaphane Loaded Fe3O4@ Gold Core Shell Nanoparticles: A Potential Sulforaphane Delivery System.
    Kheiri Manjili H; Ma'mani L; Tavaddod S; Mashhadikhan M; Shafiee A; Naderi-Manesh H
    PLoS One; 2016; 11(3):e0151344. PubMed ID: 26982588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembled nanoparticles based on amphiphilic chitosan derivative and arginine for oral curcumin delivery.
    Raja MA; Zeenat S; Arif M; Liu C
    Int J Nanomedicine; 2016; 11():4397-4412. PubMed ID: 27660435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Chitosan-Based Co-Delivery Nanosystem for Diabetes Mellitus Therapy.
    Lupascu FG; Sava A; Tătărușanu SM; Iacob AT; Dascălu A; Profire BȘ; Vasincu IM; Apotrosoaei M; Gîscă TC; Turin-Moleavin IA; Profire L
    Polymers (Basel); 2024 Jun; 16(13):. PubMed ID: 39000680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.